abstract |
The present invention relates to pharmaceutical vaccine compositions comprising at least one vaccine antigen and live immune cells. These immune cells include at least a portion of activated T cells and act as adjuvants. Also included are methods of preventing or treating diseases such as cancer, infectious diseases and autoimmune diseases using these pharmaceutical compositions. |